KH-1814
Exosome Therapy for Parkinson’s Disease
The KH-1814 project addresses the critical need for effective treatments in Parkinson's Disease (PD), a debilitating neurodegenerative disorder affecting millions worldwide, by developing a novel therapy using specialized cells from human umbilical cord.
KH-1814 targets key PD pathology including neuroinflammation, oxidative stress and dopaminergic neuron degeneration.
“KH-1814 is an exosome therapy that promises to not only alleviate PD symptoms but also potentially reverse some of the disease's damaging effects. By advancing this technology, the project seeks to fill a critical gap in current treatments and significantly enhance public health outcomes for individuals suffering from PD and potentially other neurological conditions.”
—Mercedes F. Kweh, Co-Founder & CEO